A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis
- PMID: 25595252
- DOI: 10.1016/j.jneuroim.2014.12.005
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis
Abstract
The main aim of the study was to evaluate levels of cytokines IL-1ra, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-17, TNF-alfa, TGB-beta1 and IFN-gamma in 30 patients with relapsing remitting (RRMS) compared to 30 secondary progressive multiple sclerosis (SPMS) in a peripheral blood sample. Statistical analysis showed significant higher levels of IL-17 and INF-gamma, which are cytokines with pro-inflammatory properties, and lower levels of TGF-beta1, a molecule with immunosuppressant activity, in RRMS compared to SPMS. These results underline the existence of a different cytokines dysregulation in RRMS compared to SPMS phases with higher pro-inflammatory activity in RRMS.
Keywords: Cytokines; IL-17; INF-gamma; Relapsing remitting multiple sclerosis; Secondary progressive multiple sclerosis; TGF-beta.
Copyright © 2014. Published by Elsevier B.V.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources